留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

下腔静脉滤器的临床应用现状

朱益强,  张金辉,  王元喜

downloadPDF
文章导航 > 分子影像学杂志  > 2018 >  41(4): 514-519
朱益强, 张金辉, 王元喜. 下腔静脉滤器的临床应用现状[J]. 分子影像学杂志, 2018, 41(4): 514-519. doi: 10.12122/j.issn.1674-4500.2018.04.21
引用本文: 朱益强, 张金辉, 王元喜. 下腔静脉滤器的临床应用现状[J]. 分子影像学杂志, 2018, 41(4): 514-519. doi: 10.12122/j.issn.1674-4500.2018.04.21
shu
Yiqiang ZHU, Jinhui ZHANG, Yuanxi WANG. Clinical Application of Inferior Vena Cava Filter[J]. Journal of Molecular Imaging, 2018, 41(4): 514-519. doi: 10.12122/j.issn.1674-4500.2018.04.21
Citation: Yiqiang ZHU, Jinhui ZHANG, Yuanxi WANG. Clinical Application of Inferior Vena Cava Filter[J]. Journal of Molecular Imaging, 2018, 41(4): 514-519. doi: 10.12122/j.issn.1674-4500.2018.04.21
shu

下腔静脉滤器的临床应用现状

doi: 10.12122/j.issn.1674-4500.2018.04.21

  • 南方医科大学深圳医院普通外科，广东 深圳 518000

基金项目: 国家自然科学基金(81470875)；广东省自然科学基金(2014A030312013)；广东省科技计划项目(2015B020229002)
详细信息
    作者简介:

    朱益强，在读硕士研究生，E-mail: zhuyiqiang2016@126.com

    通讯作者:

    张金辉，主任医师，硕士生导师，E-mail: zhangjinhui2001@sina.com

    王元喜，副主任医师，E-mail: wyxboy@sina.com

Clinical Application of Inferior Vena Cava Filter

  • Department of General Sursery, Shenzhen Hospital, Southern Medical University, Shenzhen 518000, China

    摘要
  • 摘要: 如今对于深静脉血栓形成患者，下腔静脉滤器（IVCF）的使用率持续增加，但其临床效益和远期并发症仍有很大争议，没有证据显示使用IVCF有生存获益性。尽管在临床实践中广泛使用IVCF，但在适应症方面各个地区却有很大差异。目前我们支持更为严格的美国胸科医师学院IVCF放置指征指南，只有在高危肺栓塞、围术期高出血风险并存在药物预防禁忌的情况下才考虑IVCF，并主张对可回收的IVCF进行密切而有组织的随访，一旦不再需要预防肺栓塞，尽快将其取出。本文全面对比了有关IVC过滤功效的随机性、前瞻性研究，比较美国和欧洲指南在IVCF适应证和并发症的差别。随着时间的推移，IVCF指南也在逐渐变化。

     

    Abstract: IVCF unilization ratio continues to increase in patients with deep venous thrombosis, but its clinical benefits and long-term complications remain controversial. There is no conclusive evidence of survival benefit with IVCF. It is widely used in clinical practice, but there are significant differences of indications in each area.We support the guidelines for placement of IVCF in the American College of Chest Physicians（ACCP）, which use IVCF only in the setting of high-risk pulmonary embolism, high perioperative bleeding risk and contraindication for drug prevention.It needs to advocate a close follow-up of the recoverable IVCF. PE should be removed as soon as it is no longer needed.In this review, we provide a comprehensive comparison of randomized, prospective studies of IVCF efficacy. IVCF guidelines are also evolving.We compare the difference between IVCF indications and complications in the U.S. and European guidelines.

     

    • HTML全文
    • 参考文献(70)
  • [1] Beckman MG, Hooper WC, Critchley SE, et al. Venous thromboembolism: a public health concern[J]. Am J Prev Med, 2010, 38(Suppl 4): S495-501
    [2] Park B, Messina L, Dargon P, et al. Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample[J]. Chest, 2009, 136(12): 983-90
    [3] Tschoe M, Kim HS, Brotman DJ, et al. Retrievable vena cava filters: a clinical review[J]. J Hosp Med, 2009, 4(7): 441-8 doi: 10.1002/jhm.v4:7
    [4] Mobin UK, Callard GM, Bolooki H, et al. Transvenous caval interruption with umbrella filter[J]. N Engl J Med, 1972, 286(4): 55-8
    [5] Greenfield LJ, McCurdy JR, Brown PP, et al. A new intracaval filter permitting continued flow and resolution of emboli[J]. Surgery, 1973, 73(9): 599-606
    [6] Kaw R, Pasupuleti V, Wayne OD, et al. Inferior vena cava filters and postoperative outcomes in patients undergoing bariatric surgery: a meta-analysis[J]. Surg Obes Relat Dis, 2014, 10(3): 725-33
    [7] PS Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study[J]. Circulation, 2005, 112(3): 416-22 doi: 10.1161/CIRCULATIONAHA.104.512834
    [8] Stern JR, Cafasso DE, Meltzer AJ, et a. Prophylactic inferior vena cava filter utilization and risk factors for nonretrieval[J]. Vasc Endovascular Surg, 2018, 52(1): 34-8 doi: 10.1177/1538574417740507
    [9] White RH, Geraghty EM, Brunson A, et al. High variation between hospitals in vena cava filter use for venous thromboembolism[J]. JAMA Intern Med, 2013, 173(7): 506-12 doi: 10.1001/jamainternmed.2013.2352
    [10] Wadhwa V, Trivedi PS, Chatterjee K, et al. Decreasing Utilization of Inferior Vena Cava Filters in Post-FDA Warning Era: Insights From 2005 to 2014 Nationwide Inpatient Sample[J]. J Am Coll Radiol, 2017, 14(9): 1144-50 doi: 10.1016/j.jacr.2017.04.022
    [11] US FDA. Removing retrievable inferior vena cava filters: initial communication[Z]. 2010.
    [12] Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis[J]. Arch Intern Med, 2011, 171(9): 831-7
    [13] Stein PD, Matta F, Hull RD. Increasing use of vena cava filters for prevention of pulmonary embolism[J]. Am J Med, 2011, 124(7): 655-61 doi: 10.1016/j.amjmed.2011.02.021
    [14] Kaufman JA1, Rundback JH, Kee ST, et al. Development of a research agenda for inferior vena cava filters: proceedings from a multidisciplinary research consensus panel[J]. J Vasc Interv Radiol, 2009, 20(6): 697-707 doi: 10.1016/j.jvir.2009.03.007
    [15] Walsh DB, Birkmeyer JD, Barrett JA, et al. Use of inferior vena cava filters in the Medicare population[J]. Ann Vasc Surg, 1995, 9(5): 483-7 doi: 10.1007/BF02143864
    [16] Meltzer AJ, Graham A, Kim JH, et al. Clinical, demographic, and medicolegal factors associated with geographic variation in inferior vena cava filter utilization: an interstate analysis[J]. Surgery., 2013, 153(5): 683-8 doi: 10.1016/j.surg.2012.11.005
    [17] Wadhwa V, Trivedi PS, Chatterjee K, et al. Decreasing Utilization of Inferior Vena Cava Filters in Post-FDA Warning Era: Insights From 2005 to 2014 Nationwide Inpatient Sample[J]. J Am Coll Radiol, 2017, 14(9): 1144-50 doi: 10.1016/j.jacr.2017.04.022
    [18] Ray CE, Prochazka A. The need for anticoagulation following inferior vena cava filter placement: systematic review[J]. Cardiovasc Intervent Radiol, 2008, 31(2): 316-24 doi: 10.1007/s00270-007-9244-x
    [19] Usoh F, Hingorani A, Ascher E, et al. Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters[J]. J Vasc Surg, 2010, 52(2): 394-9 doi: 10.1016/j.jvs.2010.02.280
    [20] Prasad V, Rho J, Cifu A. The inferior vena cava filter: how could a medical device be so well accepted without any evidence of efficacy[J]. JAMA Intern Med, 2013, 173(7): 493-5 doi: 10.1001/jamainternmed.2013.2725
    [21] Stein PD1, Matta F, Keyes DC, et al. Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism[J]. Am J Med, 2012, 125(5): 478-84 doi: 10.1016/j.amjmed.2011.05.025
    [22] Velmahos GC, Kern J, Chan LS, et al. Prevention of venous thromboembolism after injury: an evidence-based report——part II: analysis of risk factors and evaluation of the role of vena caval filters[J]. J Trauma, 2000, 49(1): 140-4 doi: 10.1097/00005373-200007000-00021
    [23] Schultz DJ, Brasel KJ, Washington L, et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients[J]. J Trauma, 2004, 56(4): 727-31 doi: 10.1097/01.TA.0000119687.23542.EC
    [24] Knudson MM, Gomez D, Haas B, et al. Three thousand seven hundred thirty-eight posttraumatic pulmonary emboli: a new look at an old disease[J]. Ann Surg, 2011, 254(4): 625-32 doi: 10.1097/SLA.0b013e3182300209
    [25] Aryafar H, Kinney TB. Optional inferior vena cava filters in the trauma patient[J]. Semin Intervent Radiol, 2010, 27(1): 68-80 doi: 10.1055/s-0030-1247890
    [26] Dossett LA, Adams RC, Cotton BA. Unwarranted national variation in the use of prophylactic inferior vena cava filters after trauma: an analysis of the National Trauma Databank[J]. J Trauma, 2011, 70(5): 1066-70 doi: 10.1097/TA.0b013e31821282d5
    [27] Froehling DA, Daniels PR, Mauck KF, et al. Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study[J]. Obes Surg, 2013, 23(11): 1874-9 doi: 10.1007/s11695-013-1073-1
    [28] Finks JF, English WJ, Carlin AM, et al. Predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative[J]. Ann Surg, 2012, 255(6): 1100-4 doi: 10.1097/SLA.0b013e31825659d4
    [29] Birkmeyer NJ, Share D, Baser O, et al. Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgery[J]. Ann Surg, 2010, 252(2): 313-8 doi: 10.1097/SLA.0b013e3181e61e4f
    [30] Birkmeyer NJ, Finks JF, English WJ, et al. Risks and benefits of prophylactic inferior vena cava filters in patients undergoing bariatric surgery[J]. J Hosp Med, 2013, 8(4): 173-7 doi: 10.1002/jhm.v8.4
    [31] Rajasekhar A, Crowther M. Inferior vena caval filter insertion prior to bariatric surgery: a systematic review of the literature[J]. J Thromb Haemost, 2010, 8(6): 1266-70 doi: 10.1111/(ISSN)1538-7836
    [32] Bass AR, Mattern CJ, Voos JE, et al. Inferior vena cava filter placement in orthopedic surgery[J]. Am J Orthop (Belle Mead NJ), 2010, 39(9): 435-9
    [33] Johanson NA, Lachiewicz PF, Lieberman JR, et al. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty[J]. J Am Acad Orthop Surg, 2009, 17(5): 183-96
    [34] Sobieraj DM, Coleman CI, Tongbram V, et al. Venous Thromboembolism Prophylaxis in Orthopedic Surgery[J]. Rockville, 2012, 12(8): 16-20
    [35] Rajasekhar A, Lottenberg R, Lottenberg L, et al. Pulmonary embolism prophylaxis with inferior vena cava filters in trauma patients: a systematic review using the meta-analysis of observational studies in epidemiology (MOOSE) guidelines[J]. J Thromb Thrombolysis, 2011, 32(9): 40-6
    [36] Rogers FB, Cipolle MD, Velmahos G, et al. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group[J]. J Trauma, 2002, 53(2): 142-64
    [37] Kaufman JA, Kinney TB, Streiff MB, et al. Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference[J]. J Vasc Interv Radiol, 2006, 17(6): 449-59
    [38] Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE Disease: CHEST Guideline and Expert Panel Report[J]. Chest, 2016, 149(7): 315-52
    [39] Baadh AS, Zikria JF, Rivoli S, et a. Indications for inferior vena cava filter placement: do physicians comply with guidelines[J]. J Vasc Interv Radiol, 2012, 26(16): 989-95
    [40] Girard P, Meyer G, Parent F, et al. Medical literature, vena cava filters and evidence of efficacy. A descriptive review[J]. Thromb Haemost, 2014, 111(5): 761-9
    [41] Stern JR, Cafasso DE, Meltzer AJ, et al. Prophylactic Inferior Vena Cava Filter Utilization and Risk Factors for Nonretrieval[J]. Vasc Endovascular Surg, 2018, 52(1): 34-8 doi: 10.1177/1538574417740507
    [42] Smouse HB, Rosenthal D, Thuong VH, et al. Long-term retrieval success rate profile for the Gunther Tulip vena cava filter[J]. J Vasc Interv Radiol, 2009, 20(7): 871-7 doi: 10.1016/j.jvir.2009.03.033
    [43] Marquess JS, Burke CT, Beecham AH, et al. Factors associated with failed retrieval of the Gunther Tulip inferior vena cava filter[J]. J Vasc Interv Radiol, 2008, 19(3): 1321-7
    [44] Angel LF, Tapson V, Galgon RE, et al. Systematic review of the use of retrievable inferior vena cava filters[J]. J Vasc Interv Radiol, 2011, 22(11): 1522-30 doi: 10.1016/j.jvir.2011.08.024
    [45] Grewal S, Chamarthy MR, Kalva SP. Complications of inferior vena cava filters[J]. Cardiovasc Diagn Ther, 2016, 6(6): 632-41 doi: 10.21037/cdt
    [46] Kinney TB. Update on inferior vena cava filters[J]. J Vasc Interv Radiol, 2003, 14(6): 425-40
    [47] Angel LF, Tapson V, Galgon RE, et al. Systematic review of the use of retrievable inferior vena cava filters[J]. J Vasc Interv Radiol, 2011, 22(4): 1522-30
    [48] Knott EM, Beacham B, Fry WR. New technique to prevent tilt during inferior vena cava filter placement[J]. J Vasc Surg, 2012, 55(6): 869-71
    [49] Greenfield LJ, Proctor MC, Cho KJ, et al. Limb asymmetry in titanium Greenfield filters: clinically significant[J]. J Vasc Surg, 1997, 26(5): 770-5 doi: 10.1016/S0741-5214(97)70089-2
    [50] Martin MJ, Blair KS, Curry TK, et al. Vena cava filters: current concepts and controversies for the surgeon[J]. Curr Probl Surg, 2010, 47(11): 524-618
    [51] Carman TL, Alahmad A. Update on vena cava filters[J]. Curr Treat Options Cardiovasc Med, 2008, 10(4): 101-11
    [52] Angel LF, Tapson V, Galgon RE, et al. Systematic review of the use of retrievable inferior vena cava filters[J]. J Vasc Interv Radiol, 2011, 22(10): 1522-30
    [53] Desai TR, Morcos OC, Lind BB, et al. Complications of indwelling retrievable versus permanent inferior vena cava filters[J]. J Vasc Surg Venous Lymphat Disord, 2014, 2(4): 166-73
    [54] Kalva SP, Wicky S, Waltman AC, et al. TrapEase vena cava filter: experience in 751 patients[J]. J Endovasc Ther, 2006, 13(12): 365-72
    [55] Nicholson W, Nicholson WJ, Tolerico P, et al. Prevalence of fracture and fragment embolization of Bard retrievable vena cava filters and clinical implications including cardiac perforation and tamponade[J]. Arch Intern Med, 2010, 170(5): 1827-31
    [56] Poudel DR, Pathak R, Karmacharya P, et al. Stuck in the Heart: Embolized Strut Fracture of IVC Filter[J]. Vasc Endovascular Surg, 2015, 49(11): 93-4
    [57] Nicholson W, Nicholson WJ, Tolerico P, et al. Prevalence of fracture and fragment embolization of Bard retrievable vena cava filters and clinical implications including cardiac perforation and tamponade[J]. Arch Intern Med, 2010, 170(8): 1827-31
    [58] Milovanovic L, Kennedy SA, Midia M. Procedural and indwelling complications with inferior vena cava filters: frequency, etiology, and management[J]. Semin Intervent Radiol, 2015, 32(1): 34-41 doi: 10.1055/s-00000068
    [59] Ahmad I, Yeddula K, Wicky S, et al. Clinical sequelae of thrombus in an inferior vena cava filter[J]. Cardiovasc Intervent Radiol, 2010, 33(5): 285-9
    [60] Milovanovic L, Kennedy SA, Midia M. Procedural and indwelling complications with inferior vena cava filters: frequency, etiology, and management[J]. Semin Intervent Radiol, 2015, 32(1): 34-41 doi: 10.1055/s-00000068
    [61] Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism[J]. Blood Rev, 2005, 19(3): 179-202
    [62] Van Ha TG, Chien AS, Funaki BS, et al. Use of retrievable compared to permanent inferior vena cava filters: a single-institution experience[J]. Cardiovasc Intervent Radiol, 2008, 31(12): 308-15
    [63] Leeper WR, Murphy PB, Vogt KN, et al. Are retrievable vena cava filters placed in trauma patients really retrievable[J]. Eur J Trauma Emerg Surg, 2016, 42(13): 459-64
    [64] Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multicenter study[J]. J Trauma Acute Care Surg, 2007, 62(3): 17-24
    [65] Duszak R, Parker L, Levin DC, et al. Placement and removal of inferior vena cava filters: national trends in the medicare population[J]. J Am Coll Radiol, 2011, 8(12): 483-9
    [66] Irwin E, Byrnes M, Schultz S, et al. A systematic method for follow-up improves removal rates for retrievable inferior vena cava filters in a trauma patient population[J]. J Trauma, 2010, 69(13): 866-9
    [67] US FDA. Removing retrievable inferior vena cava filters: FDA Safety Communication[Z]. 2014.
    [68] Durack JC, Wang JH, Schneider DB, et al. Vena cava filter scaffold to prevent migration of embolic materials in the treatment of a massive renal arteriovenous malformation[J]. J Vasc Interv Radiol, 2012, 23(5): 413-6
    [69] Yunus TE, Tariq N, Callahan RE, et al. Changes in inferior vena cava filter placement over the past decade at a large community-based academic health center[J]. J Vasc Surg, 2008, 47(6): 157-65
    [70] Uberoi R, Chalmers N, Kinsman R, et al. The first BSIR inferior vena cava filter registry report[J]. Oxfordshire UK: Dendrite Clinical Systems Ltd, 2011
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  1351
  • HTML全文浏览量:  417
  • PDF下载量:  12
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-08-05
  • 刊出日期:  2018-11-01

目录

    /

    返回文章
    返回
    • 版权所有© 2013《分子影像学杂志》编辑部 ICP备00000000号
    • 重点提示: Adobe Reader6可能造成全文显示不正常，请升级为Adobe Reader7或更高。
    • 地址: 广东省广州市广州大道北1838号 Tel: 020-61648176 E-mail: 

    本系统由 北京仁和汇智信息技术有限公司 开发  技术支持：info@rhhz.net

    x 关闭 永久关闭

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者：

    为了缩短出版时滞，促进科研成果的快速传播，我刊自2024年1月起，刊期由双月刊变更为月刊。本刊主要栏目有：基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱！

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日